PuLSE: Quality control and quantification of peptide sequences explored by phage display libraries.

PloS One
Steven ShaveManfred Auer

Abstract

The design of highly diverse phage display libraries is based on assumption that DNA bases are incorporated at similar rates within the randomized sequence. As library complexity increases and expected copy numbers of unique sequences decrease, the exploration of library space becomes sparser and the presence of truly random sequences becomes critical. We present the program PuLSE (Phage Library Sequence Evaluation) as a tool for assessing randomness and therefore diversity of phage display libraries. PuLSE runs on a collection of sequence reads in the fastq file format and generates tables profiling the library in terms of unique DNA sequence counts and positions, translated peptide sequences, and normalized 'expected' occurrences from base to residue codon frequencies. The output allows at-a-glance quantitative quality control of a phage library in terms of sequence coverage both at the DNA base and translated protein residue level, which has been missing from toolsets and literature. The open source program PuLSE is available in two formats, a C++ source code package for compilation and integration into existing bioinformatics pipelines and precompiled binaries for ease of use.

References

Feb 26, 1979·Molecular & General Genetics : MGG·H Engelberg-KulkaM Belfort
Aug 15, 1991·Nature·T ClacksonG Winter
Aug 15, 1991·Gene·F BreitlingM Little
Aug 1, 1995·Cell Biophysics·D NeriG Roncucci
Oct 1, 1995·Trends in Biotechnology·R C Ladner
Jan 1, 1994·Annual Review of Immunology·G WinterH R Hoogenboom
Aug 1, 1995·Immunotechnology : an International Journal of Immunological Engineering·D R Burton
Aug 1, 2000·Immunology Today·H R Hoogenboom, P Chames
Aug 10, 2000·Journal of Molecular Recognition : JMR·A Skerra
Feb 22, 2001·Methods : a Companion to Methods in Enzymology·K A Noren, C J Noren
Apr 1, 1997·Chemical Reviews·George P. Smith, Valery A. Petrenko
Nov 5, 2002·Clinical Biochemistry·Hassan M E Azzazy, W Edward Highsmith
Mar 4, 2003·Bioinformatics·Lee Makowski, Alexei Soares
Nov 10, 2005·Chemical Reviews·John W Kehoe, Brian K Kay
Dec 24, 2005·Protein Science : a Publication of the Protein Society·Ralf J HosseBarbara E Power
Jan 1, 2008·Nature Methods·Stephan C Schuster
Apr 1, 2008·Protein Engineering, Design & Selection : PEDS·Enrique Muñoz, Michael W Deem
Apr 9, 2008·Bioconjugate Chemistry·A González-TecheraG González-Sapienza
Apr 2, 2010·Nature Structural & Molecular Biology·John WojcikShohei Koide
Feb 18, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Thomas LindnerWalter Mier
Nov 17, 2012·Nature Protocols·Aftabul Haque, Nicholas K Tonks
Jun 29, 2013·Applied Microbiology and Biotechnology·Dexian DongP Chen
Nov 1, 2016·Biomedit︠s︡inskai︠a︡ khimii︠a︡·G A Kuzmicheva, V A Belyavskaya

❮ Previous
Next ❯

Methods Mentioned

BETA
phage display
restriction digest

Software Mentioned

Linux
NGS
PuLSE
Gzip
MultiQC
Visual C
Visual Studio
PHASTpep
PuLSE ( L Se quence E valuation )
fastqc

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.